These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2928636)

  • 21. Effect of non-absorbent intravaginal menstrual/contraceptive products on Staphylococcus aureus and production of the superantigen TSST-1.
    Schlievert PM
    Eur J Clin Microbiol Infect Dis; 2020 Jan; 39(1):31-38. PubMed ID: 31853743
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of glycerol monolaurate on growth of, and production of toxic shock syndrome toxin-1 and lipase by, Staphylococcus aureus.
    Holland KT; Taylor D; Farrell AM
    J Antimicrob Chemother; 1994 Jan; 33(1):41-55. PubMed ID: 8157573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Investigation by improved syringe method of effect of tampons on production in vitro of toxic shock syndrome toxin 1 by Staphylococcus aureus.
    Wong AC; Downs SA
    J Clin Microbiol; 1989 Nov; 27(11):2482-7. PubMed ID: 2808672
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surfactants, aromatic and isoprenoid compounds, and fatty acid biosynthesis inhibitors suppress Staphylococcus aureus production of toxic shock syndrome toxin 1.
    McNamara PJ; Syverson RE; Milligan-Myhre K; Frolova O; Schroeder S; Kidder J; Hoang T; Proctor RA
    Antimicrob Agents Chemother; 2009 May; 53(5):1898-906. PubMed ID: 19223628
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of vaginal microbial communities on colonization by Staphylococcus aureus with the gene for toxic shock syndrome toxin 1 (TSST-1): a case-control study.
    Pierson JD; Hansmann MA; Davis CC; Forney LJ
    Pathog Dis; 2018 Jun; 76(4):. PubMed ID: 29762733
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The toxic shock syndrome revisited.
    Kass EH
    Postgrad Med J; 1985; 61 Suppl 1():45-8. PubMed ID: 4059159
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of tampon composition on production of toxic shock syndrome toxin-1 by Staphylococcus aureus in vitro.
    Parsonnet J; Modern PA; Giacobbe KD
    J Infect Dis; 1996 Jan; 173(1):98-103. PubMed ID: 8537689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of air in growth and production of toxic shock syndrome toxin 1 by Staphylococcus aureus in experimental cotton and rayon tampons.
    Fischetti VA; Chapman F; Kakani R; James J; Grun E; Zabriskie JB
    Rev Infect Dis; 1989; 11 Suppl 1():S176-81. PubMed ID: 2928634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Merocel vaginal sponge on growth of Staphylococcus aureus and production of toxic shock syndrome-associated toxins.
    Schlievert PM
    J Am Coll Surg; 1996 Jul; 183(1):19-24. PubMed ID: 8673303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of cotton and cotton/rayon tampons for effect on production of toxic shock syndrome toxin.
    Schlievert PM
    J Infect Dis; 1995 Oct; 172(4):1112-4. PubMed ID: 7561191
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the pathogenesis of toxic shock syndrome.
    Kass EH; Parsonnet J
    Rev Infect Dis; 1987; 9 Suppl 5():S482-9. PubMed ID: 3317745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oxygen and carbon dioxide regulation of toxic shock syndrome toxin 1 production by Staphylococcus aureus MN8.
    Yarwood JM; Schlievert PM
    J Clin Microbiol; 2000 May; 38(5):1797-803. PubMed ID: 10790102
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contribution of toxic shock syndrome toxin-1 to systemic inflammation investigated by a mouse model of cervicovaginal infection with Staphylococcus aureus.
    Asano K; Narita K; Hirose S; Nakane A
    Med Microbiol Immunol; 2018 Nov; 207(5-6):297-306. PubMed ID: 29980843
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of tampon wraps on production of toxic shock syndrome toxin 1.
    Robbins RN; Kelly BJ; Hehl GL; Bergdoll MS
    Rev Infect Dis; 1989; 11 Suppl 1():S197-202. PubMed ID: 2928637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of antibody to toxic shock syndrome toxin-1 in burn patients.
    Park JY; Kim JS; Woo H
    Ann Lab Med; 2015 Jan; 35(1):89-93. PubMed ID: 25553286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Toxic shock syndrome toxin-1 (TSST-1): influence of its production by subinhibitory antibiotic concentrations.
    Dickgiesser N; Wallach U
    Infection; 1987; 15(5):351-3. PubMed ID: 3692606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxic shock syndrome toxin 1 (TSST-1) production by staphylococci isolated from goats and presence of specific antibodies to TSST-1 in serum and milk.
    Valle J; Vadillo S; Piriz S; Gomez-Lucia E
    Appl Environ Microbiol; 1991 Mar; 57(3):889-91. PubMed ID: 2039240
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Correlation in Staphylococcus aureus infections between toxic shock syndrome toxin-1 production and clinical feature].
    Kiyota H; Ohishi Y; Onodera S; Miki K; Ueda M
    Kansenshogaku Zasshi; 1998 Jun; 72(6):593-8. PubMed ID: 9695469
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Production of toxic shock syndrome toxin 1 in a mouse model of Staphylococcus aureus abscess formation.
    Lee JC; Perez NE; Hopkins CA
    Rev Infect Dis; 1989; 11 Suppl 1():S254-9. PubMed ID: 2928644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levels of toxic shock syndrome toxin-1 production among Staphylococcus aureus strains and clinical implications.
    Naidu AS; Kamme C; Ljungh A; Wadström T
    Zentralbl Bakteriol Mikrobiol Hyg A; 1989 Jan; 270(3):337-44. PubMed ID: 2648709
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.